Bipartisan Insulin Price Cap Introduced in House as Lawmakers Seek Affordability Win The US healthcare system is struggling under the weight of unaffordable insulin prices, leaving millions unable to access this essential medication.
A bipartisan group of lawmakers has introduced legislation capping insulin prices at $35 per month for patients with private insurance.
This proposal marks a significant step towards making healthcare more accessible and affordable for Americans.